Quarterly report pursuant to Section 13 or 15(d)

Note 7 - Investment in Macrophage Therapeutics, Inc. (Details Textual)

v3.19.3
Note 7 - Investment in Macrophage Therapeutics, Inc. (Details Textual)
Aug. 31, 2018
MT [Member] | Dr. Michael Goldberg [Member]  
Resignation Agreement, Subidiary Percentage Ownership After Signing 5.00%